Li Q - Search Results

1

The rs2233678 polymorphism in PIN1 promoter region reduced cancer risk: a meta-analysis.

Li Q, Dong Z, Lin Y, Jia X, Li Q, Jiang H, Wang L, Gao Y. Li Q, et al. PLoS One. 2013 Jul 9;8(7):e68148. doi: 10.1371/journal.pone.0068148. Print 2013. PLoS One. 2013. PMID: 23874525 Free PMC article.

2

Successful treatment of paraganglioma with sorafenib: a case report and brief review of the literature.

Lin Y, Li Q, Huang W, Jia X, Jiang H, Gao Y, Li Q. Lin Y, et al. Among authors: li q. Onco Targets Ther. 2013 Nov 5;6:1559-62. doi: 10.2147/OTT.S53813. eCollection 2013. Onco Targets Ther. 2013. PMID: 24235841 Free PMC article.

3

ChIP-seq predicted estrogen receptor biding sites in human breast cancer cell line MCF7.

Li Q, Wang H, Yu L, Zhou J, Chen J, Zhang X, Chen L, Gao Y, Li Q. Li Q, et al. Tumour Biol. 2014 May;35(5):4779-84. doi: 10.1007/s13277-014-1627-4. Epub 2014 Jan 28. Tumour Biol. 2014. PMID: 24470138

4

The effect of lipocisplatin on cisplatin efficacy and nephrotoxicity in malignant breast cancer treatment.

Li Q, Tian Y, Li D, Sun J, Shi D, Fang L, Gao Y, Liu H. Li Q, et al. Among authors: li d. Biomaterials. 2014 Aug;35(24):6462-72. doi: 10.1016/j.biomaterials.2014.04.023. Epub 2014 May 3. Biomaterials. 2014. PMID: 24797881

5

SRrp35 suppresses cell proliferation and malignancy in hepatocellular carcinoma.

Li Y, Lin Y, Li Q, Gao Y. Li Y, et al. Among authors: li q. Hepatol Res. 2015 Dec;45(12):1241-7. doi: 10.1111/hepr.12493. Epub 2015 Mar 17. Hepatol Res. 2015. PMID: 25594558

6

Association between breastfeeding and breast cancer risk: evidence from a meta-analysis.

Zhou Y, Chen J, Li Q, Huang W, Lan H, Jiang H. Zhou Y, et al. Among authors: li q. Breastfeed Med. 2015 Apr;10(3):175-82. doi: 10.1089/bfm.2014.0141. Epub 2015 Mar 18. Breastfeed Med. 2015. PMID: 25785349 Review.

7

KAP1 is overexpressed in hepatocellular carcinoma and its clinical significance.

Wang Y, Jiang J, Li Q, Ma H, Xu Z, Gao Y. Wang Y, et al. Among authors: li q. Int J Clin Oncol. 2016 Oct;21(5):927-933. doi: 10.1007/s10147-016-0979-8. Epub 2016 Apr 19. Int J Clin Oncol. 2016. PMID: 27095111

8

Quantitative proteomic study of human prostate cancer cells with different metastatic potentials.

Li Q, Li Y, Wang Y, Cui Z, Gong L, Qu Z, Zhong Y, Zhou J, Zhou Y, Gao Y, Li Y. Li Q, et al. Among authors: li y. Int J Oncol. 2016 Apr;48(4):1437-46. doi: 10.3892/ijo.2016.3378. Epub 2016 Feb 4. Int J Oncol. 2016. PMID: 26846621

9

Next-generation sequencing identifies CDKN2A alterations as prognostic biomarkers in recurrent or metastatic head and neck squamous cell carcinoma predominantly receiving immune checkpoint inhibitors.

Xue L, Tang W, Zhou J, Xue J, Li Q, Ge X, Lin F, Zhao W, Guo Y. Xue L, et al. Among authors: li q. Front Oncol. 2023 Oct 23;13:1276009. doi: 10.3389/fonc.2023.1276009. eCollection 2023. Front Oncol. 2023. PMID: 37936609 Free PMC article.

10

ZBED2 expression enhances interferon signaling and predicts better survival of estrogen receptor-negative breast cancer patients.

Liu D, Hao Q, Li J, Li Q, Wang K, Geng Q, Wu Y, Vadgama JV, Wu Y. Liu D, et al. Among authors: li j, li q. Cancer Commun (Lond). 2022 Jul;42(7):663-667. doi: 10.1002/cac2.12296. Epub 2022 Apr 29. Cancer Commun (Lond). 2022. PMID: 35486908 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66,384 results

Search Page

Filters